Categories AlphaGraphs, Earnings, Health Care
PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2023 financial results
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today.
Revenues declined 41% year-over-year to $14.2 billion, missing estimates.
The company reported a net loss of $3.37 billion, or $0.60 per share, compared to a net income of $4.9 billion, or $0.87 per share, last year. Adjusted EPS decreased 91% to $0.10 but beat expectations.
Pfizer expects revenues of $58.5-61.5 billion for the full year of 2024. Adjusted EPS is expected to be $2.05-2.25.
The stock stayed in green during premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
CarMax (KMX) Q3 2026 earnings drop on lower sales; results beat estimates
Used car retailer CarMax, Inc. (NYSE: KMX) on Thursday reported a decline in earnings for the third quarter of fiscal 2026, hurt by lower sales. However, both revenues and earnings
ACN Earnings: Key quarterly highlights from Accenture’s Q1 2026 financial results
Accenture (NYSE: ACN) reported its first quarter 2026 earnings results today. Revenues of $18.7 billion increased 6% in US dollars and 5% in local currency compared to the same period a
